newsfilter
← Latest News
GlobeNewswire·

Genocea Announces FDA Acceptance of GEN-011 IND Application

CAMBRIDGE, Mass., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that...